JPS6168469A - ６‐クロロ‐ｎ‐メチル‐２，３，４，５‐テトラヒドロ‐１ｈ‐３‐ベンズアゼピンの製造方法 - Google Patents

６‐クロロ‐ｎ‐メチル‐２，３，４，５‐テトラヒドロ‐１ｈ‐３‐ベンズアゼピンの製造方法

Info

Publication number
JPS6168469A
JPS6168469A JP60183788A JP18378885A JPS6168469A JP S6168469 A JPS6168469 A JP S6168469A JP 60183788 A JP60183788 A JP 60183788A JP 18378885 A JP18378885 A JP 18378885A JP S6168469 A JPS6168469 A JP S6168469A
Authority
JP
Japan
Prior art keywords
methyl
chloro
benzazepine
reaction
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60183788A
Other languages
English (en)
Japanese (ja)
Inventor
スタンリイ・ジヨン・ボロウスキ
トーマス・アンソニイ・ポスト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPS6168469A publication Critical patent/JPS6168469A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP60183788A 1984-09-05 1985-08-20 ６‐クロロ‐ｎ‐メチル‐２，３，４，５‐テトラヒドロ‐１ｈ‐３‐ベンズアゼピンの製造方法 Pending JPS6168469A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US647552 1984-09-05
US06/647,552 US4541954A (en) 1984-09-05 1984-09-05 Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Publications (1)

Publication Number Publication Date
JPS6168469A true JPS6168469A (ja) 1986-04-08

Family

ID=24597406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60183788A Pending JPS6168469A (ja) 1984-09-05 1985-08-20 ６‐クロロ‐ｎ‐メチル‐２，３，４，５‐テトラヒドロ‐１ｈ‐３‐ベンズアゼピンの製造方法

Country Status (19)

Country Link
US (1) US4541954A (en, 2012)
EP (1) EP0174118A3 (en, 2012)
JP (1) JPS6168469A (en, 2012)
KR (1) KR860002470A (en, 2012)
AU (1) AU581918B2 (en, 2012)
CA (1) CA1244017A (en, 2012)
DK (1) DK379985A (en, 2012)
EG (1) EG17149A (en, 2012)
ES (1) ES8609266A1 (en, 2012)
FI (1) FI853255A7 (en, 2012)
GR (1) GR852041B (en, 2012)
HU (1) HU194181B (en, 2012)
IL (1) IL76100A0 (en, 2012)
NO (1) NO853255L (en, 2012)
NZ (1) NZ213141A (en, 2012)
PH (1) PH20796A (en, 2012)
PT (1) PT81018B (en, 2012)
ZA (1) ZA856268B (en, 2012)
ZW (1) ZW13385A1 (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401595A (en) * 1991-12-06 1995-03-28 Yuasa Corporation Film type battery and layer-built film type battery
JP2007521269A (ja) * 2003-06-17 2007-08-02 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
MXPA05013366A (es) 2003-06-17 2006-04-05 Arena Pharm Inc Derivados de benzazepina utiles para el tratamiento de enfermedades asociadas con el receptor 5ht2c.
PT1838677E (pt) 2004-12-21 2009-11-16 Arena Pharm Inc Formas cristalinas do cloridrato de (r)-8-cloro-1-metil- 2,3,4,5-tetra-hidro-1h-3-benzazepina
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2518053A1 (en) * 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2008070111A2 (en) * 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
EP2288585A1 (en) * 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2611782A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 아고니스트의 비-흡습성 염
MX2015004532A (es) 2012-10-09 2016-01-20 Arena Pharm Inc Metodo de control del peso.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5892616A (ja) * 1981-11-27 1983-06-02 スミスクライン・ベツクマン・コ−ポレイシヨン アルフア−２「きつ」抗用医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US4251660A (en) * 1978-08-10 1981-02-17 Smithkline Corporation Method for preparing tetrahydroisoquinolines
US4200754A (en) * 1979-02-02 1980-04-29 Smithkline Corporation Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
EP0161350A1 (en) * 1981-11-27 1985-11-21 Smithkline Beckman Corporation Process for preparing benzazepines
IE53962B1 (en) * 1981-11-27 1989-04-26 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5892616A (ja) * 1981-11-27 1983-06-02 スミスクライン・ベツクマン・コ−ポレイシヨン アルフア−２「きつ」抗用医薬組成物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401595A (en) * 1991-12-06 1995-03-28 Yuasa Corporation Film type battery and layer-built film type battery
JP2007521269A (ja) * 2003-06-17 2007-08-02 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法
JP4920409B2 (ja) * 2003-06-17 2012-04-18 アリーナ ファーマシューティカルズ， インコーポレイテッド ３−ベンズアゼピンを調製する方法

Also Published As

Publication number Publication date
EG17149A (en) 1989-06-30
IL76100A0 (en) 1985-12-31
DK379985D0 (da) 1985-08-21
FI853255A0 (fi) 1985-08-23
EP0174118A2 (en) 1986-03-12
DK379985A (da) 1986-03-06
FI853255L (fi) 1986-03-06
FI853255A7 (fi) 1986-03-06
KR860002470A (ko) 1986-04-26
ES8609266A1 (es) 1986-09-01
PT81018B (en) 1987-06-24
ZA856268B (en) 1986-07-30
PH20796A (en) 1987-04-14
PT81018A (en) 1985-09-01
NO853255L (no) 1986-03-06
ES546285A0 (es) 1986-09-01
HU194181B (en) 1988-01-28
ZW13385A1 (en) 1985-11-20
GR852041B (en, 2012) 1985-12-19
NZ213141A (en) 1988-07-28
CA1244017A (en) 1988-11-01
HUT38617A (en) 1986-06-30
EP0174118A3 (en) 1986-12-30
US4541954A (en) 1985-09-17
AU4648185A (en) 1986-03-13
AU581918B2 (en) 1989-03-09

Similar Documents

Publication Publication Date Title
JPS6168469A (ja) ６‐クロロ‐ｎ‐メチル‐２，３，４，５‐テトラヒドロ‐１ｈ‐３‐ベンズアゼピンの製造方法
JP5254836B2 (ja) ベナゼプリル及びその類似体の生産に有用な中間体の速度論的分離
HUE033534T2 (en) Asymmetric synthesis of substituted pyrrolidine-2-carboxamide
RU2109013C1 (ru) Способ стереоселективного синтеза алкилированного оксиндола и способ получения оптически чистого энантиомера алкилированного оксиндола
US4697024A (en) Medroxalol intermediates
JP2001521498A (ja) Ｏ−（３−アミノ−２−ヒドロキシ−プロピル）−ヒドロキシミック酸ハロゲン化物の製造方法
EP0634410B1 (de) Verfahren zur Herstellung eines N-tert.Butylisochinolin-3-carboxamid Derivates und Zwischenprodukte in diesem Verfahren
US20040254385A1 (en) Process for the preparation of citalopram hydrobromide
JPH05279326A (ja) 光学活性３−ヒドロキシピロリジンの製法
JPH0617342B2 (ja) 光学活性β−アミノアルコ−ルの製造方法
US5426227A (en) Enantioselective process for the preparation of leveobunolol
KR100486320B1 (ko) 5,11-디히드로-6에이치-디벤즈[비,이]아제핀-6-온의제조방법
US4500736A (en) Hydrogenation of 3-trichlorovinylnitrobenzene
JPH05178833A (ja) Ｎ−シアノアセトアミジン誘導体の製造方法
US4701541A (en) Medroxalol intermediates
KR100654923B1 (ko) 고순도의 광학활성아미드를 연속적으로 제조하는 방법
JP3084577B2 (ja) 光学活性なアトロラクチン酸の製造方法および製造の中間体
KR19980031367A (ko) 암로디핀 베실레이트의 제조방법
FR2632303A1 (fr) Procede de preparation du 3-aminocrotonate de methyle
EP0370366A2 (en) Resolution process for benzazepine intermediates
JPS6348249A (ja) ジアリ−ルエタン誘導体およびその製造法
JPH0481983B2 (en, 2012)
JPH0441148B2 (en, 2012)
BE876900A (fr) Procede de production de pyrrolidine-2-ones a partir de 3-pyrroline-2-ones et de production de 3-pyrroline-2-ones
HU212733B (en) Process to prepare (2-benzyloxy-6-nitrophenyl)-acetonitril